Discrepancies between Cyclic and Linear Antimicrobial Peptide Actions on the Spectrochemical and Nanomechanical Fingerprints of a Young Biofilm

ACS Omega
Oona FreudenthalGrégory Francius

Abstract

Antimicrobial peptides (AMPs) are currently known for their potential as an alternative to conventional antibiotics and new weapons against drug-resistant bacteria and biofilms. In the present work, the mechanism of action of a cyclic (colistin) and a linear (catestatin) AMP on a young E. coli biofilm was deciphered from the molecular to the cellular scale. To this end, infrared spectroscopy (attenuated total reflection-Fourier transform infrared) assisted by chemometric analysis was combined with fluorescence and atomic force microscopies to address the very different behaviors of both AMPs. Indeed, the colistin dramatically damaged the bacterial cell wall and the metabolism even though its action was not homogeneous over the whole bacterial population and repopulation can be observed after peptide removal. Conversely, catestatin did not lead to major damages in the bacterial morphology but its action was homogeneous over the whole bacterial population and the cells were unable to regrow after the peptide treatment. Our results strongly suggested that contrary to the cyclic molecule, the linear one is able to cause irreversible damages in the bacterial membrane concomitantly to a strong impact on the bacterial metabolism.

References

Jul 8, 1999·International Journal of Antimicrobial Agents·J W Costerton
Dec 11, 1999·Biochimica Et Biophysica Acta·R M Epand, H J Vogel
Mar 29, 2000·Journal of Applied Microbiology·W L CochranP S Stewart
Jun 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·R. E. W. Hancock, T. J. Falla
Sep 12, 2002·Journal of Microbiological Methods·K MaquelinG J Puppels
Dec 20, 2002·Biopolymers·Yechiel Shai
Sep 2, 2003·Nature Reviews. Immunology·Tomas Ganz
Sep 4, 2003·Journal of Peptide Science : an Official Publication of the European Peptide Society·John S Davies
Dec 5, 2003·Biochimica Et Biophysica Acta·Arnaldo da Silva, Omar Teschke
Feb 11, 2005·Nature Reviews. Microbiology·Kim A Brogden
Feb 22, 2005·Cellular and Molecular Life Sciences : CMLS·J BriolatM H Metz-Boutigue
Apr 13, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Matthew E Falagas, Sofia K Kasiakou
Aug 2, 2005·Clinical Orthopaedics and Related Research·Robin Patel
Aug 26, 2006·The Lancet Infectious Diseases·Jian LiDavid L Paterson
Oct 3, 2006·Expert Review of Anti-infective Therapy·Helen Giamarellou
Dec 13, 2006·Nature Biotechnology·Robert E W Hancock, Hans-Georg Sahl
Aug 10, 2007·Acta Biochimica Et Biophysica Sinica·Jilie Kong, Shaoning Yu
Nov 6, 2007·Current Opinion in Microbiology·Kevin D Young
Jan 11, 2008·The Journal of Investigative Dermatology·Katherine A RadekRichard L Gallo
Feb 21, 2009·Langmuir : the ACS Journal of Surfaces and Colloids·Ninell P MortensenMitchel J Doktycz
Dec 17, 2009·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Fabienne QuilèsAnne Delille
Feb 2, 2010·Regulatory Peptides·Sushil K MahataDaniel T O'Connor
Feb 13, 2010·International Journal of Antimicrobial Agents·Niels HøibyOana Ciofu
Apr 24, 2010·FEMS Microbiology Reviews·Wayne A WilsonJavier Pozueta-Romero
May 12, 2011·PloS One·Pavel PolyakovGrégory Francius
May 19, 2011·Biochimica Et Biophysica Acta·Jacek T MikaBert Poolman
Jun 18, 2011·Trends in Biotechnology·Leonard T NguyenHans J Vogel
Aug 9, 2011·Expert Review of Anti-infective Therapy·Giovanni Battista OrsiMario Venditti
Sep 13, 2011·Annals of Intensive Care·Herbert SpapenPatrick M Honoré
Oct 21, 2011·Biofouling·A BridierF Dubois-Brissonnet
Nov 5, 2014·Frontiers in Microbiology·Nadim CassirPhilippe Brouqui
May 29, 2015·The Journal of Antimicrobial Chemotherapy·C FormosaE Dague

❮ Previous
Next ❯

Methods Mentioned

BETA
atomic force microscopy
AFM
fluorescence microscopy

Software Mentioned

BPSS
Bruker OPUS
Matlab

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2022 Meta ULC. All rights reserved